Claude Rimington

Title: Claude Rimington: Innovator in Photosensitizing Agents

Introduction

Claude Rimington is a notable inventor based in Son, Norway. He has made significant contributions to the field of photosensitizing agents, particularly in the context of photodynamic therapy. With a total of 2 patents, his work has implications for medical treatments and molecular photochemical processes.

Latest Patents

Rimington's latest patents focus on the development of photosensitizing agents derived from sulphonated meso-tetraphenylporphyrins. One of his inventions involves reducing a single double bond in the porphyrin macrocycle of a disulphonated meso-tetraphenylporphyrin, such as TPPS. The resulting sulphonated meso-tetraphenyl chlorins are designed for use as photosensitizing agents in the photochemical internalization of molecules and in photodynamic therapy. These compounds, along with their pharmaceutically acceptable salts, are crucial for advancing therapeutic techniques in medicine.

Career Highlights

Throughout his career, Rimington has worked with esteemed organizations, including the Norwegian Radium Hospital Research Foundation and PCI Biotech AS. His experience in these institutions has allowed him to refine his expertise in the development of innovative medical solutions.

Collaborations

Rimington has collaborated with several professionals in his field, including Greta Rimington, who serves as a Legal Representative, and Kristian Berg. These collaborations have contributed to the advancement of his research and the successful application of his inventions.

Conclusion

Claude Rimington's work in the field of photosensitizing agents showcases his innovative spirit and dedication to improving medical therapies. His patents and collaborations reflect a commitment to advancing science and technology in healthcare.